Ferrari, S., Adachi, J. D., Lippuner, K., Zapalowski, C., Miller, P. D., Reginster, J., . . . Lewiecki, E. M. (2015). Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years. Osteoporos Int.
Citación estilo ChicagoFerrari, S., et al. "Further Reductions in Nonvertebral Fracture Rate With Long-term Denosumab Treatment in the FREEDOM Open-label Extension and Influence of Hip Bone Mineral Density After 3 years." Osteoporos Int 2015.
Cita MLAFerrari, S., et al. "Further Reductions in Nonvertebral Fracture Rate With Long-term Denosumab Treatment in the FREEDOM Open-label Extension and Influence of Hip Bone Mineral Density After 3 years." Osteoporos Int 2015.